Edwards Lifesciences Corp. announced U.S. Food and Drug Administration (FDA) approval to expand use of the Edwards Sapien XT transcatheter heart valve for pulmonic valve replacement procedures.

Cardiac stem cells could be an effective treatment for a common but difficult-to-treat type of heart failure, a new study from the Cedars-Sinai Heart Institute shows.

Stratasys Ltd., the 3-D printing and additive manufacturing solutions company, will be featured at the Healthcare Information and Management Systems Society (HIMSS) 2016 conference and exhibition. This is the first time 3-D printing will be a part of the annual conference, which will take place Feb. 29 – Mar. 4 in Las Vegas.

JC Medical Inc. announced that it has successfully completed an implantation of its J-Valve bioprosthesis using the Ausper transapical delivery device in Vancouver, Canada. The J-Valve Ausper system represents the next generation of transcatheter aortic valve implantation (TAVI) systems and has been previously used in more than 100 patients in China. This operation is the first implantation of the J-Valve Ausper system outside of China.

For the first time in the United States, a clinical trial is underway that’s evaluating a device designed to treat diastolic heart failure. The first patient enrolled in the randomized, blinded study is being treated at The Ohio State University Wexner Medical Center.

February 29, 2016 — APN Health LLC announced it received U.S. Food and Drug Administration (FDA) clearance to market Navik 3D, an advanced cardiac mapping system that reduces the cost and complexity of electrophysiology procedures.

Philips announced that new clinical trial data demonstrates the benefits of its intravascular ultrasound (IVUS) technology in the diagnosis of iliofemoral venous obstruction i.e. narrowed or blocked leg veins.

February 29, 2016 — Abbott has initiated a voluntary safety notice regarding the MitraClip Delivery System to reinforce the proper procedures used to operate and deploy the device. The company received a small number of reports involving MitraClip Delivery Systems where the user was unable to separate the implantable clip from the delivery system.

Subscribe Now